Method Article

In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity

DOI:

10.3791/56629

January 29th, 2018

In This Article

Summary

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Unlike ubiquitin ligases, few E3 SUMO ligases have been identified. This modified in vitro SUMOylation protocol is able to identify novel SUMO E3 ligases by an in vitro reconstitution assay.

Abstract

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Small ubiquitin-like modifier (SUMO) modification is an important post-translational modification (PTM) that mediates signal transduction primarily through modulating protein-protein interactions. Similar to ubiquitin modification, SUMOylation is directed by a sequential enzyme cascade including E1-activating enzyme (SAE1/SAE2), E2-conjugation enzyme (Ubc9), and E3-ligase (i.e., PIAS family, RanBP2, and Pc2). However, different from ubiquitination, an E3 ligase is non-essential for the reaction but does provide precision and efficacy for SUMO conjugation. Proteins modified by SUMOylation can be identified by in vivo assay via immunoprecipitation with substrate-specific antibodies and immunoblotting with SUMO-specific antibodies. However, the demonstration of protein SUMO E3 ligase activity requires in vitro reconstitution of SUMOylation assays using purified enzymes, substrate, and SUMO proteins. Since in the in vitro reactions, usually SAE1/SAE2 and Ubc9, alone are sufficient for SUMO conjugation, enhancement of SUMOylation by a putative E3 ligase is not always easy to detect. Here, we describe a modified in vitro SUMOylation protocol that consistently identifies SUMO modification using an in vitro reconstituted system. A step-by-step protocol to purify catalytically active K-bZIP, a viral SUMO-2/3 E3 ligase, is also presented. The SUMOylation activities of the purified K-bZIP are shown on p53, a well-known target of SUMO. This protocol can not only be employed for elucidating novel SUMO E3 ligases, but also for revealing their SUMO paralog specificity.

Introduction

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

SUMO modification was initially identified as a reversible post-translational modification (PTM) that regulates protein stability1. In addition to direct conjugation, SUMO can also be attached to a protein through non-covalent interaction by SUMO interaction motifs (SIMs)2. Similar to the binding of tyrosyl-phosphorylation by molecules harboring Src homology 2 (SH2) or phosphotyrosine binding (PTB) domains3,4, SUMO modification provides an additional interaction platform for selective recruitment of SIM-containing effector proteins5,<....

Access restricted. Please log in or start a trial to view this content.

Protocol

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

1. Preparation of Baculovirus Expression Constructs

  1. Purify SUMO E3 ligase K-bZIP by cloning the cDNA of K-bZIP19 into a dual expression baculovirus vector (see Table of Materials) with an N-terminal epitope-tag. We have had success using an octapeptide tag (indicated throughout the protocol as vector-tag-K-bZIP).
    NOTE: The DNA template for K-bZIP polymerase chain reaction (PCR) cloning is cDNA reverse transcribed from RNA isolated from TREx F3H3-K-Rta BCBL-1 cells following doxycycline treatment20.
    1. Transfer the full-length K-bZIP cDNA19 into the dual....

Access restricted. Please log in or start a trial to view this content.

Results

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

According to the information provided by the manufacturer, the standard amount of E1 and E2 enzyme in the SUMOylation assay is 50 nM and 500 nM, respectively. The minimal amount of E2 conjugating enzyme Ubc9 that is able to SUMOylate p53 was first determined by an in vitro SUMOylation assay. As low as one-fifth of the amount of Ubc9 used in the standard in vitro SUMOylation assay protocol was able to efficiently SUMOylate p53 (Figure 1

Access restricted. Please log in or start a trial to view this content.

Discussion

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The in vitro SUMOylation protocol described here is routinely used to establish the SUMOylation status of identified Ubc9 substrates. The major limitation using the standard protocol to study the SUMOylation function of SUMO E3 ligase is the abundance of SUMO E1 activating and E2 conjugating enzymes Ubc9 that maximize the SUMO conjugation in in vitro systems. Considering this challenge, we believe that titration of the amount of SUMO E1 and E2 enzymes to the level that one can barely detect their activi.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The authors disclose no potential conflicts of interest.

Acknowledgements

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

This work was supported by grants from the Ministry of Science and Technology (MOST, 105-2320-B-010-007-MY3 to PCC), from the National Health Research Institute (NHRI-EX105-10215BC to PCC), from the Ministry of Science and Technology (MOST 105-2314-B-400-019 to HJK) and from the National Health Research Institute (NHRI MG-105-SP-10, NHRI MG-106-SP-10 to HJK). This work was also supported partly with National Yang-Ming University on manuscript publication to PCC. The funders had no role in study design, data collection and analysis, decision to publish, or reparation of the manuscript.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
pFastBacInvitrogen10359-016dual expression baculovirus vector
pCR2.1-TOPO vectorInvitrogenPCR product vector
competent cell  E. coli DH5αYeastern BiotechFYE678-80VLcompetent E. coli cells A
E. coli DH10BacInvitrogen10359-016competent E. coli cells B
FugeneHDRoche04709705001transfection reagent
Opti-MEMGibco31985062reduced serum media
T4 LigaseNEW England BioLabsM0202S
CpoI (RsrII)Thermo ScientificER0741
Bluo-galThermo ScientificB1690galactosidase substrate
IPTGSigma-AldrichI6758-1G
Grace’s Insect MediumGibco11605094
Fetal Bovine SerumGibco10082147
GentamicinThermo Fisher15750060
AmpicillinSigma-AldrichA9393-25G
KanamycinSigma-AldrichK0254-20ML
gentamicinGibco15710-064
tetracyclinSigma-Aldrich87128-25G
LB BrothMerk1.10285.0500
HEPESSigma-AldrichH4034-100G
NaClSigma-AldrichS9888-5KG
KClMerk1.04936.1000
Na2HPO4Sigma-AldrichS5136-500G
KH2PO4J.T.Baker3246-01
sodium dodecyl sulfateMerk1.13760.1000
β-mercaptoethanolBio-Rad161-0710
TRIS (Base)J.T.Baker4109-06
Non-fat milkFonterra
glycerolJ.T.Baker2136-01
Triton X-100Amresco0694-1Ldetergent A
Tween 20Amresco0777-500MLdetergent B
Poloxamer 188 solutionSigma-AldrichP5556-100MLdetergent C
Protease Inhibitor Cocktail TabletRoche04 693 132 001
3x Flag peptideSigmaF4799
anti-FLAG m2 Magnetic beadsSigma-AldrichM8823antibody-tagged magnetic beads
SUMOlink SUMO-1 KitActive Motif40120standard SUMOylation protocol 
SUMOlink SUMO-2/3 KitActive Motif40220standard SUMOylation protocol 
QIAquick Gel Extraction KitQIAGEN28704
QIAGEN Plasmid Mini KitQIAGEN12123plasmid extraction kit
Polypropylene tubesFalcon352059
Petri DishFalcon351029
Cell lifterCorningCNG3008
Loading tipSorenson BioScience28480
PVDFPerkinElmerNEF1002
Blotting filter paperBio-Rad1703932
Mini slab gel apparatus (Bio-Rad Mini Protean II Cell)Bio-Rad1658001 EDU
Trans-Blot SD Semi-Dry Electrophoretic Transfer CellBio-Rad1703940
Pierce ECL Western BlottingThermo32106ECL reagent
suspension mixerDigisystem laboratory instruments  Inc.SM-3000
orbital shakerKansin instruments Co.OS701
ImageQuant LAS 4000
biomolecular imager
GE Healthcare28955810
Sf9Thermo ScientificB82501
anti-p53 antibodyCell Signaling#9282
anti-rabbit antibodyGE HealthcareNA934-1ML

References

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,
  1. Bies, J., Markus, J., Wolff, L. Covalent attachment of the SUMO-1 protein to the negative regulatory domain of the c-Myb transcription factor modifies its stability and transactivation capacity. J Biol Chem. 277 (11), 8999-9009 (2002).
  2. Lin, D. Y., et al.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Tags

In Vitro ReconstitutionK bZIP Purificationp53 SUMOylationUbc9 EnzymeSDS Page AnalysisWestern BlottingMagnetic BeadsBaculovirus Expression

Related Articles